Neurociencias

L I F E L O N G L E A R N I N G I N N E U R O L O G Y®

SPINAL CORD, ROOT, AND PLEXUS
DISORDERS
Volume 14

Number 3

June 2008

FACULTY

NEERAJ KUMAR, MD, CHAIR
Associate Professor, College of Medicine, Mayo Clinic, Rochester, Minnesota;
Consultant, Department of Neurology, Mayo Clinic, Rochester, Minnesota
*†
Dr Kumar has nothing to disclose.

´
JOSE BILLER, MD, FACP, FAHA,FAAN
Professor and Chairman, Department of Neurology, Loyola University Chicago,
Stritch School of Medicine, Chicago, Illinois
*†
Dr Biller has nothing to disclose.

THOMAS COCHRANE, MD, MBA
Instructor in Neurology, Harvard Medical School, Boston, Massachusetts
*†
Dr Cochrane has nothing to disclose.

JOHN K. FINK, MD
Professor, University of Michigan, Department of Neurology andGeriatric
Research, Education & Clinic Center, Ann Arbor, Michigan; Research Scientist, Ann
Arbor Veterans Affairs Medical Center, Ann Arbor, Michigan
*
Dr Fink has received personal compensation from Athena Diagnostics, Inc.
Dr Fink has received royalty payments for atlastin and NIPA1 patents.
†
Dr Fink has nothing to disclose.

JEREMY L. FOGELSON, MD
Neurosurgery Resident, Mayo Clinic,Rochester, Minnesota
*†
Dr Fogelson has nothing to disclose.

DAVID S. GELDMACHER, MD
Harrison Distinguished Teaching Associate Professor of Neurology, University of
Virginia, Charlottesville, Virginia
*
Dr Geldmacher has received personal compensation for activities with Eisai
Inc./Pfizer Inc, Forest Pharmaceuticals, Inc., Medical Care Corporation, Novartis
Pharmaceuticals, Inc., and TakedaPharmaceuticals, Inc. Dr Geldmacher has
received grant or research support from Eisai Inc., Elan Pharmaceuticals, Inc.,
Myriad Pharmaceuticals, Inc., and GlaxoSmithKline.
†
Dr Geldmacher has nothing to disclose.

GREGORY GRUENER, MD, MBA
Professor of Neurology, Associate Chairman, Associate Dean of Educational
Affairs, Loyola University of Chicago, Stritch School of Medicine, Chicago,Illinois
*
Dr Gruener has received personal compensation for speaking engagements
with Medical Education Resources, Inc.
†
Dr Gruener has nothing to disclose.

WILLIAM E. KRAUSS, MD
Associate Professor of Neurological Surgery, Mayo Medical School, Rochester,
Minnesota
*
Dr Krauss has nothing to disclose.
†
Dr Krauss’s presentation includes figures of, but does not discuss, the
unlabeleduse of cervical pedicle screws.

KERRY H. LEVIN, MD
Chairman, Department of Neurology, Director, Neuromuscular Center, Cleveland
Clinic; Professor of Neurology, Cleveland Clinic Lerner College of Medicine of
Case Western Reserve University, Cleveland, Ohio
*†
Dr Levin has nothing to disclose.

DEVON I. RUBIN, MD
Associate Professor of Neurology, Director, EMG Laboratory, Mayo Clinic,Jacksonville, Florida
*
Dr Rubin has received royalty payments for contributing to an EMG
educational CD-ROM from AAN Enterprises, Inc., and the American Association
of Neuromuscular and Electrodiagnostic Medicine.
†
Dr Rubin has nothing to disclose.

LUBDHA SHAH, MD
Assistant Professor, Radiology, University of Virginia Health System, Charlottesville,
Virginia
*†
Dr Shah has nothing todisclose.

DEAN M. WINGERCHUK, MD, MSc, FRCP(C), FAAN
Associate Professor of Neurology, Consultant, Department of Neurology, Mayo
Clinic, Scottsdale, Arizona
*
Dr Wingerchuk has received personal compensation for activities with
Genentech, Inc. Dr Wingerchuk has received research support to Mayo Clinic
from the National Multiple Sclerosis Society and Genzyme Corporation.
†
Dr Wingerchukdiscusses the unlabeled use of methylprednisolone,
plasmapheresis, and cyclophosphamide for the treatment of myelitis attacks;
carbamazepine for tonic spasms; and prednisone, azathioprine, mycophenolate
mofetil, cyclophosphamide, mitoxantrone, intravenous immune globulin, and
rituximab for prevention of relapse of certain inflammatory myelitides.

MULTIPLE-CHOICE QUESTION WRITERS...